Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort

This SCETIDE study on SCID transplants is the first to report similar 2-year event free survival for genetic subgroups. Absolute na ïve CD4 T-lymphocytes numbers at 1-year post-transplant strongly predict an uncomplicated clinical and immunological outcome

Source: Journal of Allergy and Clinical Immunology - October 27, 2021 Category: Allergy & Immunology Authors: Arjan C. Lankester, Benedicte Neven, Nizar Mahlaoui, Erik GJ. von Asmuth, Virginie Courteille, Mikael Alligon, Michael H. Albert, Isabelle Badell Serra, Peter Bader, Dmitry Balashov, Rita Beier, Yves Bertrand, Stephane Blanche, Victoria Bordon, Robbert G. Source Type: research